A detailed history of Vontobel Holding Ltd. transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Vontobel Holding Ltd. holds 37,398 shares of RCKT stock, worth $527,685. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37,398
Previous 38,544 2.97%
Holding current value
$527,685
Previous $829,000 16.77%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$17.6 - $25.88 $20,169 - $29,658
-1,146 Reduced 2.97%
37,398 $690,000
Q2 2024

Aug 13, 2024

SELL
$20.66 - $26.72 $85,862 - $111,048
-4,156 Reduced 9.73%
38,544 $829,000
Q1 2024

May 10, 2024

SELL
$26.16 - $30.74 $21,974 - $25,821
-840 Reduced 1.93%
42,700 $1.15 Million
Q4 2023

Jun 03, 2024

SELL
$16.78 - $31.94 $105,026 - $199,912
-6,259 Reduced 12.57%
43,540 $1.3 Million
Q4 2023

Jan 29, 2024

BUY
$16.78 - $31.94 $730,601 - $1.39 Million
43,540 New
43,540 $1.3 Million
Q1 2023

Jun 03, 2024

BUY
$15.79 - $22.6 $112,093 - $160,437
7,099 Added 16.63%
49,799 $853,000
Q1 2023

Apr 12, 2023

SELL
$15.79 - $22.6 $136,599 - $195,512
-8,651 Reduced 14.8%
49,799 $853,000
Q4 2022

Feb 14, 2023

BUY
$15.5 - $22.76 $905,975 - $1.33 Million
58,450 New
58,450 $1.14 Million
Q2 2022

Jul 27, 2022

SELL
$7.96 - $16.64 $293,819 - $614,215
-36,912 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$13.16 - $23.68 $21,134 - $38,030
-1,606 Reduced 4.17%
36,912 $589,000
Q4 2021

Feb 14, 2022

BUY
$21.52 - $36.02 $828,907 - $1.39 Million
38,518 New
38,518 $883,000
Q3 2021

Oct 29, 2021

SELL
$27.42 - $48.97 $190,706 - $340,586
-6,955 Closed
0 $0
Q2 2021

Aug 06, 2021

SELL
$39.41 - $47.25 $1.63 Million - $1.96 Million
-41,391 Reduced 85.61%
6,955 $301,000
Q1 2021

May 11, 2021

BUY
$43.34 - $65.91 $44,466 - $67,623
1,026 Added 2.17%
48,346 $2.15 Million
Q4 2020

Feb 12, 2021

BUY
$23.3 - $59.57 $1.1 Million - $2.82 Million
47,320 New
47,320 $3.12 Million

Others Institutions Holding RCKT

About ROCKET PHARMACEUTICALS, INC.


  • Ticker RCKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 75,683,696
  • Market Cap $1.07B
  • Description
  • Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...
More about RCKT
Track This Portfolio

Track Vontobel Holding Ltd. Portfolio

Follow Vontobel Holding Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Vontobel Holding Ltd. with notifications on news.